Artemisinin

A recent study has warned that regions with heavy artemisinin usage and favourable environmental conditions could emerge as new hotspots for artemisinin resistance. The study also highlights that in some parts of Africa, the frequency of resistance markers is gradually increasing, which could threaten the effectiveness of malaria treatment in the future.

Background and Discovery

Artemisinin is an antimalarial drug derived from the sweet wormwood plant (Artemisia annua). The drug is obtained by drying the leaves and using a solvent to extract the active compound. The therapeutic benefits of artemisinin were discovered in the 1970s, marking a major breakthrough in malaria treatment, especially at a time when parasites were developing resistance to chloroquine and sulfadoxine-pyrimethamine.

Mechanism of Action

Artemisinin is effective against all malaria-causing Plasmodium species. It primarily acts on the blood stage of the parasite, where it disrupts the parasite’s ability to replicate within red blood cells, leading to a rapid reduction in parasite load.

Pharmacological Characteristics

One of the key features of artemisinin is its short half-life, as it is eliminated from the body within a few hours. Due to this, artemisinin alone cannot completely eliminate the malaria parasite, and there is a risk of developing resistance if used as monotherapy.

Artemisinin-Based Combination Therapy (ACT)

To overcome its short duration, artemisinin is always used in combination with a longer-acting partner drug. The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) as the first-line treatment for Plasmodium falciparum malaria. This combination therapy prevents treatment failure and slows the emergence of resistance.

Derivatives and Clinical Importance

Several derivatives of artemisinin, including artesunate and artemether, are widely used. Artesunate is particularly important because it is highly effective in severe malaria and is the only artemisinin derivative that can be administered intravenously, making it critical in emergency care.

Source: THE HINDU

Join Our Telegram

AI Impact Summit 2026 UPSC GS-3 S&T PT-MAINS

India’s Indo-Pacific Oceans Initiative (IPOI) UPSC GS-2 INDO PACIFIC – IR/PSIR

20 Nov, 25
SHARE

India’s Indo-Pacific Oceans Initiative (IPOI) UPSC GS-2 INDO PACIFIC – IR/PSIR IPOI is India’s open, voluntary and non-treaty-based maritime initiative for building a free, open, inclusive and rules-based Indo-Pacific through practical cooperation. Why in News? India’s Indo-Pacific Oceans Ini

AI Impact Summit 2026 UPSC GS-3 S&T PT-MAINS

19 May, 26
SHARE

AI Impact Summit 2026 UPSC GS-3 S&T PT-MAINS The India-AI Impact Summit 2026 positioned India as a Global South leader by shifting global AI debate from only AI safety and regulation to AI for development, inclusion and real-world impact. Why in News? India hosted the India-AI Impact Summit 2026 at B

Hong Kong Convention for Safe Ship Recycling UPSC GS-3 ENVIRONMENT PT-MAINS

27 Jun, 25
SHARE

Hong Kong Convention for Safe Ship Recycling UPSC GS-3 ENVIRONMENT PT-MAINS The Hong Kong International Convention, 2009 is an IMO treaty that ensures ships are recycled safely without unnecessary risk to human health, worker safety and the environment. Why in News? The Hong Kong Convention entered into force on 26 June 2

LeadIT 2.0: Leadership Group for Industry Transition COP28 UPSC GS-2 IR GS-3 S&T

14 Nov, 23
SHARE

LeadIT 2.0: Leadership Group for Industry Transition UPSC GS-2 IR GS-3 S&T LeadIT 2.0 is the second phase of the India-Sweden-led global initiative to support low-carbon transition in hard-to-abate industrial sectors. Why in News? The second phase of LeadIT was announced at the LeadIT Summit 2023, ho

India-EFTA Trade and Economic Partnership Agreement UPSC GS-2 IR/PSIR

03 Sep, 25
SHARE

India-EFTA Trade and Economic Partnership Agreement UPSC GS-2 IR/PSIR The India-EFTA TEPA is a comprehensive trade pact between India and four non-EU European countries — Iceland, Liechtenstein, Norway and Switzerland — aimed at boosting trade, investment, jobs, services, technology and supply-chain resilience. Wh